Sinovac (SVA) COO Gao Qiang discloses direct holding of 230,000 shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
SINOVAC BIOTECH LTD executive Gao Qiang, the Chief Operation Officer, has filed an initial ownership report showing direct holdings of 230,000 common shares. This Form 3 does not report any new purchase or sale, only the number of shares he beneficially owns after the reported holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
GAO QIANG (NMN)
Role
Chief Operation Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common shares, par value $0.001 per share | -- | -- | -- |
Holdings After Transaction:
Common shares, par value $0.001 per share — 230,000 shares (Direct)
Footnotes (1)
FAQ
What does SINOVAC (SVA) COO Gao Qiang report in this Form 3?
Gao Qiang reports his existing ownership stake in SINOVAC. The filing shows he directly holds 230,000 common shares. Form 3s are initial ownership statements, so this reflects his beneficial holdings rather than a new market transaction.
What type of security is reported in the SINOVAC (SVA) Form 3 for Gao Qiang?
The security reported is common shares of SINOVAC. The filing specifies common shares with a par value of $0.001 per share, reflecting standard equity ownership rather than options or other derivative securities.
Does SINOVAC (SVA) COO Gao Qiang hold any derivative securities in this Form 3?
No derivative securities are listed for Gao Qiang. The derivative section is empty, indicating only common shares are reported, with 230,000 common shares shown as directly owned following the reported holdings.